INVO Fertility, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
INVO Fertility, Inc. (IVF) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $888.74 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-14
- INVO Fertility, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $888.74K.
- INVO Fertility, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$5.54M.
- INVO Fertility, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $1.10M.
- INVO Fertility, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$3.40M.
- INVO Fertility, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$5.34M.
- INVO Fertility, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$7.74M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $888.74K 10-Q · filed 2026-08-14 | -$4.65M 10-Q · filed 2026-08-14 | -$3.56M derived: sum of 3 quarters · filed 2026-08-14 | -$6.95M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$5.54M 10-Q · filed 2026-06-22 | -$4.44M derived: sum of 2 quarters · filed 2026-06-22 | -$7.84M derived: sum of 3 quarters · filed 2026-06-22 | -$9.38M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $1.10M derived: 10-K 12 month − 10-K 9 month · filed 2026-06-02 | -$2.30M derived: sum of 2 quarters · filed 2026-06-02 | -$3.84M derived: sum of 3 quarters · filed 2026-08-14 | -$5.34M 10-K · filed 2026-06-02 | |||
| 2025-09-30 | -$3.40M 10-K · filed 2026-06-02 | -$2.64M 10-Q · filed 2025-11-17 | -$4.94M derived: sum of 2 quarters · filed 2026-08-14 | -$6.43M 10-K · filed 2026-06-02 | -$7.35M 10-Q · filed 2025-11-17 | -$8.70M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$1.54M 10-Q · filed 2026-08-14 | -$3.21M 10-Q · filed 2025-08-14 | -$3.04M 10-Q · filed 2026-08-14 | -$4.70M 10-Q · filed 2025-08-14 | -$5.30M derived: sum of 3 quarters · filed 2026-08-14 | -$6.93M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$1.49M 10-Q · filed 2026-06-22 | -$3.76M derived: sum of 2 quarters · filed 2026-06-22 | -$5.39M derived: sum of 3 quarters · filed 2026-06-22 | -$7.64M derived: sum of 4 quarters · filed 2026-06-22 | |||
| 2024-12-31 | -$2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-02 | -$3.90M derived: sum of 2 quarters · filed 2026-06-02 | -$6.14M derived: sum of 3 quarters · filed 2026-06-02 | -$7.74M 10-K · filed 2026-06-02 | |||
| 2024-09-30 | -$1.63M 10-Q · filed 2025-11-17 | -$3.88M derived: sum of 2 quarters · filed 2025-11-17 | -$5.47M 10-Q · filed 2025-11-17 | ||||
| 2024-06-30 | -$2.25M 10-Q · filed 2025-08-14 | -$3.84M 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |